Limestone Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$70.4K Sell
200
-700
-78% -$250K 0.01% 362
2025
Q4
$295K Buy
+900
New +$285K 0.03% 284
2025
Q3
Sell
-2,100
Closed -$586K 539
2025
Q2
$586K Buy
+2,100
New +$595K 0.05% 238

Other funds holding AMGN

Limestone Investment Advisors's AMGN Position: Q1 2026 in Review

Limestone Investment Advisors sold out of Amgen (AMGN) in Q1 2026, closing a stake of 320 shares — an estimated $114K sold.

Limestone Investment Advisors first reported a position in AMGN in Q4 2025 and held it in 1 quarter. The position peaked at $105K in Q4 2025. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Limestone Investment Advisors reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Limestone Investment Advisors sold 320 Amgen shares in Q1 2026, an estimated $114K.
  • Limestone Investment Advisors first reported a position in Amgen in Q4 2025 and held it in 1 quarter.
  • Limestone Investment Advisors's Amgen position peaked at $105K in Q4 2025.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Limestone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.